Novel in vitro and in vivo models and potential new therapeutics to break the vicious cycle of cryptosporidium infection and malnutrition

Journal of Infectious Diseases

Volumn 205, Issue 9, 2012, Pages 1464-1471

  Costa, Lourrany B ^a,b   Noronha, Francisco Jose ^a,b   Roche, James K ^a   Sevilleja, Jesus Emmanuel ^a   Warren, Cirle A ^a   Oriá, Reinaldo ^b   Lima, Aldo ^b   Guerrant, Richard L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLGLUTAMINE; CPG OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; COLON ADENOCARCINOMA; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALNUTRITION; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; REPRODUCIBILITY; WEIGHT REDUCTION;

ANIMALS; CELL LINE, TUMOR; COLON; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIPEPTIDES; DNA, PROTOZOAN; FECES; FEMALE; HUMANS; ILEUM; MALNUTRITION; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES;

EID: 84861569494     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis216     Document Type: Article

References (35)

1. Guerrant RL, Oria RB, Moore SR, Oria MO, Lima AA. Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev 2008; 66:487-505.
2. Opintan JA, Newman MJ, Ayeh-Kumi PF, et al. Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition. Am J Trop Med Hyg 2010; 83:936-43.
3. Guerrant RL, Hughes JM, Lima NL, Crane J. Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Rev Infect Dis 1990; 12(Suppl 1):S41-50.
4. Arora DR, Arora B. AIDS-associated parasitic diarrhoea. Indian J Med Microbiol 2009; 27:185-90.
5. Cabada MM, White AC Jr. Treatment of cryptosporidiosis: do we know what we think we know? Curr Opin Infect Dis 2010; 23:494-9.
6. Tzipori S, Griffiths JK. Natural history and biology of Cryptosporidium parvum. Adv Parasitol 1998; 40:5-36.
7. Mutwiri G, van Drunen Littel-van den Hurk S, Babiuk LA. Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides. Adv Drug Deliv Rev 2009; 61:226-32.
8. Klinman DM, Klaschik S, Sato T, Tross D. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases. Adv Drug Deliv Rev 2009; 61:248-55.
9. Vollmer J, Krieg AM. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv Drug Deliv Rev 2009; 61:195-204.
10. Carneiro BA, Fujii J, Brito GA, et al. Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro. Infect Immun 2006; 74:81-7.
11. Haynes TE, Li P, Li X, et al. L-Glutamine or L-alanyl-L-glutamine prevents oxidant-or endotoxin-induced death of neonatal enterocytes. Amino Acids 2009; 37:131-42.
12. Braga-Neto MB, Warren CA, Oria RB, et al. Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro. Dig Dis Sci 2008; 53:2687-96.
13. Ladd FV, Ladd AA, Ribeiro AA, et al. Zinc and glutamine improve brain development in suckling mice subjected to early postnatal malnutrition. Nutrition 2010; 26:662-70.
14. Brito GA, Carneiro-Filho B, Oria RB, Destura RV, Lima AA, Guerrant RL. Clostridium difficile toxin A induces intestinal epithelial cell apoptosis and damage: role of Gln and Ala-Gln in toxin A effects. Dig Dis Sci 2005; 50:1271-8.
15. Ziegler TR, Evans ME, Fernandez-Estivariz C, Jones DP. Trophic and cytoprotective nutrition for intestinal adaptation, mucosal repair, and barrier function. Annu Rev Nutr 2003; 23:229-61.
16. Lima AA, Brito LF, Ribeiro HB, et al. Intestinal barrier function and weight gain in malnourished children taking glutamine supplemented enteral formula. J Pediatr Gastroenterol Nutr 2005; 40:28-35.
17. Carneiro-Filho BA, Bushen OY, Brito GA, Lima AA, Guerrant RL. Glutamine analogues as adjunctive therapy for infectious diarrhea. Curr Infect Dis Rep 2003; 5:114-9.
18. Parr JB, Sevilleja JE, Samie A, et al. Detection and quantification of Cryptosporidium in HCT-8 cells and human fecal specimens using realtime polymerase chain reaction. Am J Trop Med Hyg 2007; 76:938-42.
19. Coutinho BP, Oria RB, Vieira CM, et al. Cryptosporidium infection causes undernutrition and, conversely, weanling undernutrition intensifies infection. J Parasitol 2008; 94:1225-32.
20. Wang D, Kandimalla ER, Yu D, Tang JX, Agrawal S. Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity. Vaccine 2005; 23:2614-22.
21. Bushen OY, Davenport JA, Lima AB, et al. Diarrhea and reduced levels of antiretroviral drugs: improvement with glutamine or alanylglutamine in a randomized controlled trial in northeast Brazil. Clin Infect Dis 2004; 38:1764-70.
22. Dillingham RA, Lima AA, Guerrant RL. Cryptosporidiosis: epidemiology and impact. Microbes Infect 2002; 4:1059-66.
23. Sasahara T, Maruyama H, Aoki M, et al. Apoptosis of intestinal crypt epithelium after Cryptosporidium parvum infection. J Infect Chemother 2003; 9:278-81.
24. Adams RB, Guerrant RL, Zu S, Fang G, Roche JK. Cryptosporidium parvum infection of intestinal eipthelium: morphologic and functional studies in an in vivo model. J Infect Dis 1994; 169:170-7.
25. Griffiths JK, Theodos C, Paris M, Tzipori S. The gamma interferon gene knockout mouse: a highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum. J Clin Microbiol 1998; 36:2503-8.
26. Mead JR, Arrowood MJ, Sidwell RW, Healey MC. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Infect Dis 1991; 163:1297-304.
27. Surl CG, Kim HC. Concurrent response to challenge infection with Cryptosporidium parvum in immunosuppressed C57BL/6N mice. J Vet Sci 2006; 7:47-51.
28. Tzipori S, Rand W, Theodos C. Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum. J Infect Dis 1995; 172:1160-4.
29. Katona P, Katona-Apte J. The interaction between nutrition and infection. Clin Infect Dis 2008; 46:1582-8.
30. Guerrant DI, Moore SR, Lima AA, Patrick PD, Schorling JB, Guerrant RL. Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four to seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg 1999; 61:707-13.
31. Moore SR, Lima NL, Soares AM, et al. Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children. Gastroenterology 2010; 139:1156-64.
32. Newman RD, Sears CL, Moore SR, et al. Longitudinal study of Cryptosporidium infection in children in northeastern Brazil. J Infect Dis 1999; 180:167-75.
33. Roche JK, Cabel A, Sevilleja J, Nataro J, Guerrant RL. Enteroaggregative Escherichia coli (EAEC) impairs growth while malnutrition worsens EAEC infection: a novel murine model of the infection malnutrition cycle. J Infect Dis 2010; 202:506-14.
34. Barrier M, Lacroix-Lamande S, Mancassola R, et al. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice. J Infect Dis 2006; 193:1400-7.
35. Lacroix-Lamande S, Rochereau N, Mancassola R, Barrier M, Clauzon A, Laurent F. Neonate intestinal immune response to CpG oligodeoxynucleotide stimulation. PLoS One 2009; 4:e8291.